|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 401/14 | (2013.01) | ||
| A61P 31/18 | (2018.01) | ||
| A61K 31/454 | (2013.01) |
| (11) | Number of the document | 3668860 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18778575.3 |
| Date of filing the European patent application | 2018-08-16 | |
| (97) | Date of publication of the European application | 2020-06-24 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/000248 |
| Date | 2018-08-16 |
| (87) | Number | WO 2019/035973 |
| Date | 2019-02-21 |
| (30) | Number | Date | Country code |
| 201762546974 P | 2017-08-17 | US |
| (72) |
HOUSTON, Travis, Lee , US
SHI, Bing , US
|
| (73) |
Gilead Sciences, Inc. ,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | CHOLINE SALT FORMS OF AN HIV CAPSID INHIBITOR |
| CHOLINE SALT FORMS OF AN HIV CAPSID INHIBITOR |